Synergy between tumor immunotherapy and antiangiogenic therapy (Q56967585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

23 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

23 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

23 December 2023

author name string

Smita Nair

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

David Boczkowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

Benjamin Moeller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

Mark Dewhirst

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

Johannes Vieweg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

Eli Gilboa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

language of work or name

English

0 references

publication date

3 April 2003

0 references

10 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:12689940

23 December 2023

0 references

102

0 references

issue

3

0 references

page(s)

964-971

0 references

cites work

Cancer undefeated

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

The makings of a tumor rejection antigen

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Progress in human tumour immunology and immunotherapy

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

23 December 2023

Cancer vaccines

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Tumor angiogenesis: therapeutic implications

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

23 December 2023

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Noninvasive visualization of tumors in rodent dorsal skin window chambers

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

VEGFs, receptors and angiogenesis

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

23 December 2023

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Anti-angiogenic agents: clinical trial design and therapies in development

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Tumour vasculature as a target for anticancer therapy.

23 December 2023

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Signaling Vascular Morphogenesis and Maintenance

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target

23 December 2023

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

A survey of telomerase activity in human cancer

23 December 2023

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

23 December 2023

45

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

A cancer therapy resistant to resistance

23 December 2023

47

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses

23 December 2023

48

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

An innate sense of danger

23 December 2023

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?

23 December 2023

51

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-12-3738

23 December 2023

Identifiers

0 references